Artesunate

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Key facts

Artesunate is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 2020. Recorded indications include Falciparum malaria and Vivax malaria.

• Approval status: ofp (first approved 2020 by the FDA).
• Indications: Falciparum malaria and Vivax malaria.
• ATC code: P01BE03 (Artemisinin and derivatives, plain).
• Molecular formula: C19H28O8; molecular weight 384.43 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

• Falciparum malaria
• Vivax malaria

Regulatory approvals (2)

Date	Agency	Marketed as	Applicant	Orphan
2021-11-22	EMA	—	AMIVAS IRELAND LTD	Yes
2020-05-26	FDA	—	AMIVAS	Yes

ATC classification

ATC code	Therapeutic hierarchy
P01BE03	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, plain
P01BF02	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations
P01BF03	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations
P01BF04	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations
P01BF06	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations
P01BF09	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Haemolytic anaemia	275.4

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Artesunate is on its molecule page.

• Molecular formula: C₁₉H₂₈O₈
• Molecular weight: 384.43 g/mol
• CAS number: 88495-63-0
• InChIKey: FIHJKUPKCHIPAT-AHIGJZGOSA-N
• PubChem CID: 6917864

C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Artesunate used for?

DrugCentral lists the following indications for Artesunate: Falciparum malaria and Vivax malaria.

When was Artesunate first approved?

Artesunate was first approved by the FDA in 2020.

What is the chemical formula of Artesunate?

Artesunate has the molecular formula C19H28O8 and a molecular weight of 384.43 g/mol.

Sources

• DrugCentral drug card 247 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL361497 — compound record and bioactivity
• PubChem CID 6917864 — chemical identifiers
• DrugBank DB09274 — drug record
• FDA UNII 60W3249T9M — substance identity
• DailyMed: FDA labels for Artesunate — current prescribing information (label search)
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.